Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Hari Gorla

  • Home
  • Author: Hari Gorla

Merck & Co and BMS set to retain their positions as current and future key players in head and neck cancer, says GlobalData

Merck & Co. and Bristol-Myers Squibb (BMS) have transformed the treatment paradigm in advanced and metastatic head and neck squamous cell carcinoma (HNSCC) settings by improving real-world patient outcomes in the first and second-line metastatic setting. These two companies are expected to retain their position as market leaders in HNSCC, primarily based on proven product […]
Read more

Brands must focus on replicating meat-eating experience without the need for animal products to support sustainability, says GlobalData

42% of global shoppers say that they are unlikely to choose plant-based (vegan) alternatives to conventional red meat while 32% prefer the alternatives 27% of global consumers admit that one key reason for consuming plant-based alternatives to meat or dairy products is sustainability. Animal welfare is also on the list, at 33% To avoid alienating […]
Read more

UK involvement in Tejas Mk.2 would be major victory for industry, says GlobalData

Following the news that UK Prime Minister Boris Johnson and Indian Prime Minister Narendra Modi laid out a roadmap for cooperation between the two countries, including an expression of intent to cooperate in strategic partnership within defense and security. Harry Boneham, Aerospace and Defense Associate Analyst at GlobalData, a leading data and analytics company, offers […]
Read more

Russia, China lead global small-scale LNG liquefaction capacity additions by 2025, says GlobalData

Russia and China are expected to lead the global small-scale LNG liquefaction capacity additions, together contributing 43% of the total small-scale liquefaction capacity additions between 2021 and 2025, says GlobalData, a leading data and analytics company. GlobalData’s report,  Global Small-Scale LNG Liquefaction Capacity and Capital Expenditure Outlook, 2021–2025 – Russia and China Lead Global Capacity […]
Read more

Europe the most committed territory for tourist board sport sponsorship with 80 active deals in 2021, according to GlobalData

European tourist boards account for roughly two thirds of the sectors active sponsorship agreements with the sports industry. The tourist board sector sees 123 active deals in 2021, with European tourist boards accounting for 80 partnerships. France and Spain, the two most popular travel destinations globally, are the most active countries with a combined 40 […]
Read more

Results from post hoc study may bolster current use of Veltassa among older patients with CKD-HK, says GlobalData

A post hoc analysis of the multicenter AMETHYST-DN study found that the use of Vifor Pharma’s Veltassa (patiromer) significantly reduced serum potassium in patients ages 75 years and older with chronic kidney disease (CKD)-related hyperkalemia (HK). This study could be of high clinical value to physicians with elderly patients looking to find an optimal treatment […]
Read more

Carbon capture and storage playing field is dominated by oil giants with no room for smaller operators, says GlobalData

The oil and gas playing field will become increasingly difficult for small and medium sized producers, as the world is pushing towards energy transition. Smaller operators will need government intervention to incentivise carbon capture to promote investments, because these companies will have to expend relatively more resources to lower their emissions as compared to oil […]
Read more

Harley-Davidson accelerates job postings in 2021, gears-up to increase ridership, finds GlobalData

Harley-Davidson has taken a multi-pronged strategy to boost ridership, develop its dealer network, and to build customer-dealer relationships. Job positions in January 2021 indicate the company is strengthening its dealer network by advising on ways to increase sales and also consulting with dealers on how to boost product development, finds GlobalData, a leading data and […]
Read more

Freeline Therapeutics edges ahead of gene therapy competitors by progressing dose escalation for FLT190 Phase I/II study, says GlobalData

Freeline Therapeutics recently announced plans to progress dose escalation for its Phase I/II trial for FLT190, an adeno-associated variant (AAV) based gene therapy for Fabry disease. The current position that Freeline has achieved with FLT190 places the company ahead of its direct competitors and into a strategic position to dominate the Fabry gene therapy landscape, […]
Read more

Unmet needs in T1D highlight significant market gaps despite robust pipeline, according to GlobalData

It is expected that 15 therapeutics will launch in the Type 1 Diabetes (T1D) market in the eight major markets (8MM*) before 2030. They include Adocia’s BioChaperone Insulin lispro, an ultra-fast prandial insulin; Zealand Pharma’s dasiglucagon, a liquid-stable glucagon to manage hypoglycemia for use in a bihormonal pump; and Provention Bio’s teplizumab, the first preventative […]
Read more
1 … 54 55 56 57 58 … 60